High pCR Rates With Dual Neoadjuvant Immunotherapy in TIL-High TNBC
High pathological response rates were seen in patients with triple-negative breast cancer that took two cycles of dual neoadjuvant immunotherapy in phase 2 BELLINI trial. ...